Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas

^aFrom Nottingham University Hospitals National Health Service Trust (T.J., P.S.M.), Nottingham, UK
^bWürzburg University (M.W.-M.), Würzburg, Germany
^cVU University Medical Center (E.S.A.), Amsterdam, the Netherlands
^dLeeds Teaching Hospital National Health Service Trust (D.W.), Leeds, West Yorkshire, UK
^eAssistance Publique–Hôpitaux de Paris (R.C.), Paris, France
^fGustave Roussy and Paris-Sud University (J.Grill), Villejuif, France
^gGreat Ormond Street Hospital (D.H.), London, UK
^hF. Hoffmann-La Roche (J.Garcia, G.Z.), Basel, Switzerland.

Please address correspondence to Tim Jaspan, MD, Imaging Centre, B Floor, Nottingham University Hospitals National Health Service Trust, Nottingham, NG7 2UH, UK; e-mail: tjaspan{at}doctors.org.uk